The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Efficacy in treatment of diarrhea
To evaluate the efficacy of CASAD 3 grams per day in reducing the severity of diarrhea after 1 week of treatment in patients with MTC.
United States: Food and Drug Administration
|MD Anderson Cancer Center||Houston, Texas 77030-4096|